VALNEVA |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.444 EUR | -0.06% |
|
-5.95% | -27.03% |
| 11/04 | Valneva: Deep Track Biotechnology Master holds less than 5% of the capital | CF |
| 26/03 | Valneva Kicks Off Early-stage Trial for Zika Vaccine Candidate | MT |
Chart calendar Valneva
7d113f0d553e325dd4.MY3Jh7RqbduHmbBwIQ6ELvYZ-rUpWPECCbAVzdpyFEI.d6D7wZlSKLPe1uEjQDfPRqd-quBLP6ZXfsRDuvcGRygJ_ZO1wyE1q9fdiA~6855b98e39d61cc1f1f8acf53a82d388
Upcoming events on Valneva
Past events on Valneva
| 16/04/2024 | Van Lanschot Kempen Life Sciences Conference |
| 01/04/2024 | World Vaccine Congress |
| 20/03/2024 07:30 pm | Q4 2023 Earnings Call |
| 20/03/2024 11:30 am | Q4 2023 Earnings Release |
| 04/03/2024 | TD Cowen Health Care Conference |
| 15/02/2024 11:30 am | Q4 2023 Sales and Revenue Release |
| 07/02/2024 09:00 pm | Guggenheim Healthcare Talks Biotechnology Conference |
| 15/01/2024 | Oddo BHF Forum |
| 08/01/2024 | JPMorgan Healthcare Conference |
| 20/12/2023 06:30 pm | Extraordinary Shareholders Meeting |
| 14/11/2023 08:00 pm | Jefferies London Healthcare Conference |
| 13/11/2023 07:30 pm | IXCHIQ FDA Approval Call |
| 12/11/2023 | International Society for Pharmacoeconomics and Outcomes Research European Congress |
| 09/11/2023 07:30 pm | Q3 2023 Earnings Call |
| 09/11/2023 11:30 am | Q3 2023 Earnings Release |
| 24/10/2023 01:15 pm | International Society of Vaccines Congress |
| 20/10/2023 10:45 pm | American Society of Tropical Medicine and Hygiene Meeting |
| 20/10/2023 09:30 pm | American Society of Tropical Medicine and Hygiene Meeting |
| 16/10/2023 | World Vaccine Congress |
| 16/10/2023 | World Vaccine Congress |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 126 124 1.84% | 110 121 -8.96% | 348 103 237.38% | 361 342 5.67% | 154 168 -8.63% | 192 |
|
EBITDA Million EUR | Released Forecast Spread | 7,80 10,6 -26.16% | -45,2 -42,9 -5.26% | -47,1 -31,6 -48.94% | -69,2 -30,3 -128.36% | -65,2 -65,1 -0.21% | 53,8 |
|
EBIT Million EUR | Released Forecast Spread | -0,81 1,73 -146.99% | -55,1 -52,7 -4.61% | -61,4 -63,7 3.55% | -113 -33,8 -235.21% | -82,1 -58,3 -40.89% | 31,7 |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | -0,87 -3,96 78.01% | -65,3 -64,1 -1.95% | -70,0 55,6 -225.97% | -145 -84,4 -71.58% | -98,6 -91,3 -7.99% | 22,7 |
|
Net income Million EUR | Released Forecast Spread | -1,70 -4,87 65.1% | -64,4 -62,7 -2.74% | -73,4 -64,3 -14.14% | -143 -85,4 -67.77% | -101 -90,8 -11.69% | 25,4 |
|
EPS EUR | Released Forecast Spread | -0,02 -0,05 56.1% | -0,71 -0,69 -3.5% | -0,75 -0,61 -22.95% | -1,24 -0,59 -110.17% | -0,73 -0,52 -41.42% | 0,15 |
| Announcement Date | 27/02/20 | 25/02/21 | 03/02/22 | 23/03/23 | 21/03/24 | - |
Quarterly results
| Fiscal Period | December | 2020 S1 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 S1 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 47,9 72,5 -33.92% | 278 26,9 934.85% | 21,8 22,6 -3.57% | 71,4 21,4 232.96% | 93,2 45,3 105.69% | 157 116 34.81% | 111 90,0 23.73% | 33,5 30,4 10.29% | 40,2 33,1 21.5% | 38,1 41,4 -8.06% | 41,9 83,4 -49.74% | 66,6 | 38,0 | 43,2 | 52,2 |
|
EBITDA Million EUR | Released Forecast Spread | 12,5 -31,8 139.43% | -13,3 -48,7 72.69% | -123 -43,0 -185.35% | -5,20 | |||||||||||
|
EBIT Million EUR | Released Forecast Spread | -21,9 -9,20 -138.35% | 11,1 -37,2 129.87% | -18,4 -69,6 73.56% | -129 -45,2 -185.02% | -147 -98,9 -48.8% | 93,3 36,2 158.09% | -56,4 34,9 -261.4% | -16,6 -21,5 22.8% | -20,3 -18,4 -9.98% | -22,2 -22,5 1.16% | -24,9 24,5 -201.85% | 77,4 | -20,0 | -16,0 | -15,6 |
|
EPS EUR | Released Forecast Spread | -0,13 -0,14 7.14% | -0,12 -0,13 7.69% | -0,25 -0,12 -108.33% | -0,23 -0,14 -64.29% | 0,60 | -0,09 | -0,12 | -0,11 | |||||||
| Announcement Date | 04/08/20 | 03/02/22 | 05/05/22 | 11/08/22 | 11/08/22 | 10/11/22 | 23/03/23 | 04/05/23 | 21/09/23 | 09/11/23 | 21/03/24 | - | - | - | - |
More events
Past sector events for Valneva
| 27/04/2024 | GEMPHARMATECH CO., LTD.: Q1 2024 Earnings Release |
| 27/04/2024 | GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 26/04/2024 10:30 am | BB BIOTECH AG: Q1 2024 Earnings Release |
| 26/04/2024 | BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 26/04/2024 | PHARMARESOURCES (SHANGHAI) CO., LTD.: Q1 2024 Earnings Release |
| 26/04/2024 | HINOVA PHARMACEUTICALS INC.: Q1 2024 Earnings Release (Projected) |
| 26/04/2024 | BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q4 2023 Earnings Release |
| 26/04/2024 | CHEMPARTNER PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 25/04/2024 04:30 pm | MORPHIC HOLDING, INC.: Q1 2024 Earnings Release |
| 25/04/2024 11:30 am | PURETECH HEALTH PLC: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- VLA Stock
- Calendar Valneva
